1. Home
  2. LASE vs GALT Comparison

LASE vs GALT Comparison

Compare LASE & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laser Photonics Corporation

LASE

Laser Photonics Corporation

HOLD

Current Price

$2.23

Market Cap

62.7M

Sector

Industrials

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$3.20

Market Cap

261.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LASE
GALT
Founded
2019
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.7M
261.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
LASE
GALT
Price
$2.23
$3.20
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.50
AVG Volume (30 Days)
405.3K
804.3K
Earning Date
12-23-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,140,614.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
132.01
N/A
52 Week Low
$1.71
$1.07
52 Week High
$6.77
$7.13

Technical Indicators

Market Signals
Indicator
LASE
GALT
Relative Strength Index (RSI) 39.58 28.84
Support Level $1.90 $3.34
Resistance Level $2.53 $4.35
Average True Range (ATR) 0.25 0.41
MACD -0.02 -0.13
Stochastic Oscillator 34.04 0.27

Price Performance

Historical Comparison
LASE
GALT

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: